MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0014834
Innings Pharmaceuticals Private Limited
Innings Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹62.87 Lakh
▲ 9% YoY
Net profit · FY 2025
₹80,600
Net margin 1.3%
EBITDA · FY 2025
₹2.19 Lakh
EBITDA margin 3.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Innings Pharmaceuticals Private Limited
Data last updated:
Innings Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC314181. Its GSTIN is 07AAECI4169H1ZG (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Kapoor and Anu Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 25 Vandana Appartments Sector – 13 Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.87 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹80,600 (net margin 1.3%) and EBITDA of ₹2.19 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 11% over five years.
Innings Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0014834). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2017PTC314181
Registration Number 314181
Incorporation Date 09 March 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0014834
Key People
Sanjay Kapoor Director Anu Kapoor Director Recognitions & Rankings of Innings Pharmaceuticals
Contact details
Innings Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 25 Vandana Appartments Sector – 13 Rohini, Delhi, India – 110085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Innings Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Innings Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Innings Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Innings Pharmaceuticals Private Limited, buy the company report.
Financials of Innings Pharmaceuticals Private Limited
FY 2025 filings availableInnings Pharmaceuticals Private Limited reported revenue of ₹62.87 Lakh (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹62.87 Lakh ▲ 9%
Net profit · FY 2025
₹80,600 margin 1.3%
EBITDA · FY 2025
₹2.19 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 13%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▼ 3%
5 years · compounded
▲ 26%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 9% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹80,600 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innings Pharmaceuticals Private Limited, buy the company report.
Board of directors of Innings Pharmaceuticals Private Limited
Innings Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kapoor | Director | 09 Mar 2017 | 9 Years 7 Months | Current |
| Anu Kapoor | Director | 09 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Innings Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Acer Pharmaceuticals Private Limited | ₹62.91 Lakh (FY 2025) | 32.0% | Chennai, Tamil Nadu, India | |||
| H Zone Remedies Private Limited | ₹62.91 Lakh (FY 2015) | 28.0% | New Delhi, Delhi, India | |||
| Innings Pharmaceuticals Private Limitedthis company | ₹62.87 Lakh (FY 2025) | ₹80,600 | 1.3% | 9.0% | Delhi, India | |
| Organcare Pharmaceuticals Private Limited | ₹62.81 Lakh (FY 2025) | 28.0% | Indore, Madhya Pradesh, India | |||
| Arya Remedies Private Limited | ₹62.7 Lakh (FY 2023) | -13.0% | Patna, Bihar, India |
To see the full peer comparison of Innings Pharmaceuticals Private Limited, buy the company report.
Auditor
Innings Pharmaceuticals Private Limited is audited by U K J AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| U K J AND ASSOCIATES | FY 2023 | 024608N |
Shareholding
The shareholding of Innings Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Innings Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Innings Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innings Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Innings Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECI4169H1ZG | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Innings Pharmaceuticals Private Limited, buy the company report.
Recent activity
Innings Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anu Kapoor was appointed as Director on 09 Mar 2017.
AGM
Innings Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Innings Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Anu Kapoor was appointed as Director.
Appointed
Sanjay Kapoor was appointed as Director.
Incorporation
09 Mar 2017
Innings Pharmaceuticals Private Limited was registered on 09 Mar 2017 with Roc Delhi & aged 9 years 7 months as per MCA records.
Frequently asked questions
Innings Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 March 2017 (9+ years old) and is registered under CIN U74999DL2017PTC314181.
Innings Pharmaceuticals has 2 current directors:
- Sanjay Kapoor - Director
- Anu Kapoor - Director
The latest financial statements of Innings Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Innings Pharmaceuticals is 07AAECI4169H1ZG, registered in Delhi.
The CIN (Corporate Identification Number) of Innings Pharmaceuticals is U74999DL2017PTC314181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innings Pharmaceuticals was incorporated on 09 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Innings Pharmaceuticals by revenue are Acer Pharmaceuticals Private Limited, H Zone Remedies Private Limited, Organcare Pharmaceuticals Private Limited, Arya Remedies Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Anu Kapoor was appointed as Director on 09 Mar 2017. Sanjay Kapoor was appointed as Director on 09 Mar 2017.
Yes, Innings Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0014834).
The registered office of Innings Pharmaceuticals is at B – 25 Vandana Appartments Sector – 13 Rohini, Delhi, India – 110085.
Innings Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages